Literature DB >> 30531443

Women's experience of vulvovaginal symptoms associated with menopause.

Jan L Shifren1, Rebekah Zincavage2, Ellen L Cho2, Ashley Magnavita2, David J Portman3, Michael L Krychman4, James A Simon5, Sheryl A Kingsberg6, Raymond C Rosen2.   

Abstract

OBJECTIVE: This study describes women's experiences of the genitourinary syndrome of menopause (GSM) elicited through focus groups and cognitive debriefing sessions during development of a novel patient-reported outcome measure (PROM) designed for use in both clinical care and research.
METHODS: A draft questionnaire to identify and assess bothersome genitourinary symptoms associated with estrogen deficiency in menopausal women was developed in five discrete phases from multiple sources of information in accordance with standards for PROM development. GSM was confirmed by report of symptoms in conjunction with a confirmatory pelvic examination and laboratory assessments.
RESULTS: Qualitative content interviews were completed in 36 menopausal women with GSM. Cognitive testing of draft PROM items was performed in nine focus groups, including 26 menopausal women with and 15 without GSM. Participants reported a range of symptoms and described associated impacts on more than 15 quality-of-life domains. The majority of women reported that their symptoms impacted their sexual functioning and had a negative effect on their overall quality of life. GSM affected many aspects of menopausal women's lives beyond sexual function, with descriptions of pain when walking, urinating, wearing tight clothes, and with other activities of daily living.
CONCLUSIONS: Women's own words methodically recorded and analyzed during qualitative interviews and cognitive debriefing focus groups illuminate the subjective experience of women with GSM. It is hoped that the PROM currently in development will provide an effective tool for increasing our understanding of the prevalence, predictors, and impact of GSM in menopausal women's lives.

Entities:  

Mesh:

Year:  2019        PMID: 30531443     DOI: 10.1097/GME.0000000000001275

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  4 in total

Review 1.  Vaginal Vitamin E for Treatment of Genitourinary Syndrome of Menopause: A Systematic Review of Randomized Controlled Trials.

Authors:  Laura Porterfield; Nyajuok Wur; Zuleica Santiago Delgado; Farha Syed; Amanda Song; Susan C Weller
Journal:  J Menopausal Med       Date:  2022-04

2.  Comparison of Severity of Genitourinary Syndrome of Menopause Symptoms After Carbon Dioxide Laser vs Vaginal Estrogen Therapy: A Systematic Review and Meta-analysis.

Authors:  Yeu-Chai Jang; Chi Yan Leung; Hsi-Lan Huang
Journal:  JAMA Netw Open       Date:  2022-09-01

Review 3.  Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.

Authors:  Rossella E Nappi; Ellis Martini; Laura Cucinella; Silvia Martella; Lara Tiranini; Alessandra Inzoli; Emanuela Brambilla; David Bosoni; Chiara Cassani; Barbara Gardella
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-21       Impact factor: 5.555

4.  Protocol for development of a core outcome set for menopausal symptoms (COMMA).

Authors:  Bobae V Kim; Stamatina Iliodromiti; Monica Christmas; Robin Bell; Sarah Lensen; Martha Hickey
Journal:  Menopause       Date:  2020-12       Impact factor: 3.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.